Search results for "ALLERGEN"

showing 10 items of 253 documents

Allergic contact dermatitis in patients with frontal fibrosing alopecia: An international multi‐center study

2020

Frontal fibrosing alopecia (FFA) mainly affects the anterior hairline and eyebrows and its etiology and associated factors remain obscure. The aim of this study was to evaluate the allergic contact dermatitis with patch test in patients with FFA. In this prospective study, 20 patients with FFA and 24 age and sex-matched healthy individuals were evaluated with patch testing. Diagnosis was made histologically, clinically and based on dermoscopic findings. Demographic data, age of onset, disease duration and FFA severity index are evaluated in all patients. Positive patch test reaction to one or more allergen was observed in 65% of patients while it was 37.5% in control group (P = .003). There…

medicine.medical_specialtyDermatologymedicine.disease_cause030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAllergenQuality of lifemedicineHumansProspective StudiesProspective cohort studyAllergic contact dermatitisbusiness.industryFrontal fibrosing alopeciaLichen PlanusPatch testAlopeciaGeneral Medicinemedicine.diseaseDermatology030220 oncology & carcinogenesisDermatitis Allergic ContactQuality of LifeEtiologyAge of onsetbusinessDermatologic Therapy
researchProduct

Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: A Systematic Review and Meta-analysis.

2015

IMPORTANCE: Randomized clinical trials (RCTs) and meta-analyses of sublingual immunotherapy (SLIT) for the treatment of seasonal allergic rhinoconjunctivitis (SARC) have shown a modest clinical benefit compared with placebo. Furthermore, indirect comparison by meta-analyses showed that subcutaneous immunotherapy is more effective than SLIT. Despite these data, SLIT has become the most prescribed treatment of SARC in Europe in recent years, and it was approved by the US Food and Drug Administration for the treatment of SARC to grass pollen in the United States on April 1, 2014. OBJECTIVE: To assess the efficacy and safety of the grass pollen sublingual tablets licensed as drugs in the treatm…

medicine.medical_specialtyMEDLINECochrane LibraryPlaceboPlant Extractlaw.inventionRandomized controlled triallawInternal medicineInternal MedicinemedicineClinical endpointmedia_common.cataloged_instanceHumansEuropean unionAdverse effectmedia_commonConjunctivitis AllergicSublingual Immunotherapybusiness.industryPlant ExtractsAllergenMedicine (all)Rhinitis Allergic SeasonalAllergensAntigens PlantMeta-analysisImmunologybusinessHumanJAMA internal medicine
researchProduct

Nonceliac gluten sensitivity.

2014

During the past decade there has been an impressive increase in popularity of the gluten-free diet (GFD)—now the most trendy alimentary habit in the United States and other countries. According to recent surveys, as many as 100 million Americans will consume gluten-free products within a year. Operating under the concept that the GFD benefits only individuals with celiac disease, health care professionals have struggled to separate the wheat from the chaff; there are claims that eliminating gluten from the diet increases health and helps with weight loss, or even that gluten can be harmful to every human being. However, apart from unfounded trends, a disorder related to ingestion of gluten …

medicine.medical_specialtyPathologyGlutensMolecular Sequence DataGluten sensitivityDiseaseIrritable Bowel SyndromeDiet Gluten-FreeWeight lossPredictive Value of TestsRisk FactorsTerminology as TopicHealth caremedicineAnimalsHumansAmino Acid SequenceIntensive care medicineIrritable bowel syndromechemistry.chemical_classificationHepatologybusiness.industryGastroenterologynutritional and metabolic diseasesFeeding BehaviorAllergensmedicine.diseaseHuman beingGlutendigestive system diseasesDietCeliac DiseaseTreatment Outcomechemistrymedicine.symptombusinessFODMAPFood HypersensitivityGastroenterology
researchProduct

Adherence issues related to sublingual immunotherapy as perceived by allergists.

2010

Silvia Scurati1, Franco Frati1, Gianni Passalacqua2, Paola Puccinelli1, Cecile Hilaire1, Cristoforo Incorvaia3, Italian Study Group on SLIT Compliance 1Scientific and Medical Department, Stallergenes, Milan, Italy; 2Allergy and Respiratory Diseases, Department of Internal Medicine, Genoa; 3Allergy/Pulmonary Rehabilitation, ICP Hospital, Milan, ItalyObjectives: Sublingual immunotherapy (SLIT) is a viable alternative to subcutaneous immunotherapy to treat allergic rhinitis and asthma, and is widely used in clinical practice in many European countries. The clinical efficacy of SLIT has been established in a number of clinical trials and meta-analyses. However, because SLIT is self-administered…

medicine.medical_specialtyPathologygenetic structuresefficacyAlternative medicineMedicine (miscellaneous)Adherence Cost Efficacy Side effects Sublingual immunotherapySettore MED/10 - Malattie Dell'Apparato Respiratoriosublingual immunotherapyALLERGENcostmedicineSubcutaneous immunotherapySublingual immunotherapyadherenceClinical efficacyIntensive care medicinePharmacology Toxicology and Pharmaceutics (miscellaneous)sublingual immunoterapyOriginal ResearchAsthmaAEROALLERGENSadherence; sublingual immunotherapy; efficacy; cost; side effectsbusiness.industryHealth Policymedicine.diseaseSliteye diseasesClinical trialside effectsPatient Preference and Adherenceadherence; sublingual immunoterapy; efficacy; cost; side effects.immunotherapysense organsAllergistsADHERENCE TO TREATMENTbusinessSocial Sciences (miscellaneous)
researchProduct

Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients

2020

Introduction: CSJ117 is a potent neutralizing antibody fragment against human Thymic stromal lymphopoietin (TSLP), formulated as a PulmoSol™ engineered powder in hard capsules for delivery to the lungs via dry powder inhaler. Methods: In this double-blind, placebo-controlled study, 28 mild, atopic asthmatics meeting elibility criteria were randomized to receive 4mg CSJ117 (n = 15) or placebo (n = 13) inhaled daily for 12 weeks. Allergen inhalation challenge (AIC) was conducted at screening, day 42 and day 84. The primary efficacy variable was the late asthmatic response (LAR), measured 3 to 7 hours after AIC at day 84. Other outcomes included the early asthmatic response (EAR) measured with…

medicine.medical_specialtyThymic stromal lymphopoietinInhalationbusiness.industryrespiratory systemPlacebomedicine.disease_causeGastroenterologyDry-powder inhalerrespiratory tract diseasesAllergenInternal medicineExhaled nitric oxidemedicineSputumBronchoconstrictionmedicine.symptombusinessAirway pharmacology and treatment
researchProduct

Very late reactions in the patch test with fragrance mix I and oak moss absolute (Evernia prunastri, INCI): Data of the Information Network of Depart…

2022

medicine.medical_specialtyTime Factors610 Medicine & healthDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineActive sensitizationmedicineImmunology and AllergyHumansddc:610610 Medicine & healthFragrance mixAllergic contact dermatitisbiologybusiness.industryParmeliaceaePatch testAbsolute (perfumery)AllergensPatch Testsmedicine.diseasebiology.organism_classificationMossDermatology030228 respiratory systemOdorantsbusiness
researchProduct

The role of nickel in foods exacerbating nickel contact dermatitis

1998

medicine.medical_specialtybusiness.industryImmunologychemistry.chemical_elementmedicine.disease_causemedicine.diseaseDermatitis ContactDermatologyNickelAllergenchemistryNickelImmunologyImmunology and AllergyMedicineHumansbusinessContact dermatitisFood Hypersensitivity
researchProduct

Validity and repeatability of the Pediatric Allergy Questionnaire for Athletes (AQUAped) for the screening of atopy.

2020

BACKGROUND High atopy prevalence has been reported in athletes. Having an age-specific questionnaire for predicting atopy is important for an optimal management of young athletes. The study objectives were as follows: (i) developing a scoring system for the Pediatric Allergy Questionnaire for Athletes (AQUAped); (ii) identifying the optimal age target within the range 7-14 years; (iii) assessing AQUAped validity and repeatability in the identified target population. METHODS A total of 133 young athletes (age 7-14 years) were recruited. Following a screening visit, the participants filled AQUAped at baseline (T0) and after 7 days (T1), concomitantly undergoing skin prick testing. Using atopy…

medicine.medical_specialtyvalidityAdolescentImmunologyatopymedicine.disease_causeAtopy03 medical and health sciences0302 clinical medicineSettore MED/38 - Pediatria Generale E SpecialisticachildrenInternal medicineSurveys and QuestionnairesmedicineHypersensitivityImmunology and AllergyHumansMass Screening030212 general & internal medicinerepeatabilityChildSkin Testsyoung athletesReceiver operating characteristicbiologyAthletesbusiness.industryscreeningAQUApedInfant NewbornAeroallergenGold standard (test)Repeatabilitybiology.organism_classificationmedicine.diseaseOptimal management030228 respiratory systemAthletesPediatrics Perinatology and Child HealthPediatric allergybusinessPediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and ImmunologyREFERENCES
researchProduct

Comparison of adjuvant and adjuvant-free murine experimental asthma models

2009

Introduction The most widely used protocol for the induction of experimental allergic airway inflammation in mice involves sensitization by intraperitoneal (i.p.) injections of the antigen ovalbumin (OVA) used in conjunction with the adjuvant aluminium hydroxide (alum). Although adjuvants are frequently used, there are questions regarding the necessity of alum for murine asthma studies due to the non-physiological nature of this chemical. Objective The objective of this study was to compare experimental asthma phenotypes between adjuvant and adjuvant-free protocols of murine allergic airway inflammation in an attempt to develop a standardized alternative to adjuvant use. Method An adjuvant-…

medicine.medical_treatmentC57BL/6Aluminum HydroxideintraperitonealMicechemistry.chemical_compoundImmunology and AllergySensitizationMice Inbred BALB CbiologyAluminium hydroxiderespiratory systemPhenotypemedicine.anatomical_structuresubcutaneousFemaleBronchial HyperreactivityBALB/cAdjuvantInjections IntraperitonealOvalbuminInjections SubcutaneousImmunologyOriginal Articles:Experimental Models of Allergic Diseaseβ-galactosidaseSensitivity and Specificitycomplex mixturesBALB/cadjuvantAdjuvants ImmunologicAntigenmedicineAnimalsSkin TestsAsthmaAlumbusiness.industryanimal modelAllergensbeta-Galactosidasebiology.organism_classificationmedicine.diseaseAsthmabehaviourrespiratory tract diseasesMice Inbred C57BLDisease Models AnimalOvalbuminalumchemistryImmunologybiology.proteinbusinessClinical & Experimental Allergy
researchProduct

Molekulārās sensibilizācijas profila pret suņiem saistība ar astmas un alerģiska rinīta kontroles rādītājiem

2022

Izpētes objekts Šis pētījums tika veikts, lai novērtētu suņa alergēnu molekulu sensitizāciju saistību ar astmu un alerģisko rinītu. Pētījuma metodoloģija Tika analizēti dati pacientiem, kuriem veikta ALEX vai ALEX2 paneļa testēšana un iegūts sensitizāciju profils katrai suņa alergēna molekulai (Can f 1, Can f 2, Can f 3, Can f 4, Can f 5 un Can f 6). Iegūtie dati tika analizēti kopā ar pacienta datiem par astmu un alerģisko rinītu. Rezultāti Molekulārā sensitizācija pret Can f 1, Can f 2 un Can f 6 uzrādīja statistiski nozīmīgu ietekmi uz astmas risku, taču, kad tika izslēgta sensitizācija pret citu dzīvnieku epitēliju, tikai Can f 1 un Can f 2 uzrādīja statistiski nozīmīgu ietekmi. Arī poz…

molecular testingallergic rhinitisdog allergen moleculesALEXasthmaMedicīna
researchProduct